NO843377L - Fremgangsmaate ved fremstilling av terapeutisk aktive azurenderivater - Google Patents

Fremgangsmaate ved fremstilling av terapeutisk aktive azurenderivater

Info

Publication number
NO843377L
NO843377L NO843377A NO843377A NO843377L NO 843377 L NO843377 L NO 843377L NO 843377 A NO843377 A NO 843377A NO 843377 A NO843377 A NO 843377A NO 843377 L NO843377 L NO 843377L
Authority
NO
Norway
Prior art keywords
azurend
derivatives
procedure
preparation
therapeutic active
Prior art date
Application number
NO843377A
Other languages
English (en)
Other versions
NO158673B (no
NO158673C (no
Inventor
Kahei Takase
Masafumi Yasunami
Tsuyoshi Tomiyama
Akira Tomiyama
Takashi Yanagisawa
Original Assignee
Kotobuki Seiyaku Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from JP15318783A external-priority patent/JPS6048960A/ja
Priority claimed from JP1402884A external-priority patent/JPS60158160A/ja
Application filed by Kotobuki Seiyaku Co Ltd filed Critical Kotobuki Seiyaku Co Ltd
Publication of NO843377L publication Critical patent/NO843377L/no
Publication of NO158673B publication Critical patent/NO158673B/no
Publication of NO158673C publication Critical patent/NO158673C/no

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C309/00Sulfonic acids; Halides, esters, or anhydrides thereof
    • C07C309/01Sulfonic acids
    • C07C309/28Sulfonic acids having sulfo groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton
    • C07C309/45Sulfonic acids having sulfo groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton containing nitrogen atoms, not being part of nitro or nitroso groups, bound to the carbon skeleton
    • C07C309/47Sulfonic acids having sulfo groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton containing nitrogen atoms, not being part of nitro or nitroso groups, bound to the carbon skeleton having at least one of the sulfo groups bound to a carbon atom of a six-membered aromatic ring being part of a condensed ring system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/21Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/255Esters, e.g. nitroglycerine, selenocyanates of sulfoxy acids or sulfur analogues thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C309/00Sulfonic acids; Halides, esters, or anhydrides thereof

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Emergency Medicine (AREA)
  • Epidemiology (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
NO843377A 1983-08-24 1984-08-23 Analogifremgangsmaate ved fremstilling av terapeutisk aktive azurenderivater. NO158673C (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP15318783A JPS6048960A (ja) 1983-08-24 1983-08-24 アズレン誘導体及びその製法並びにこの化合物を有効成分とする抗潰瘍剤
JP1402884A JPS60158160A (ja) 1984-01-28 1984-01-28 アズレン誘導体スルホン酸塩、抗潰瘍、抗炎症剤及びその製法

Publications (3)

Publication Number Publication Date
NO843377L true NO843377L (no) 1985-02-25
NO158673B NO158673B (no) 1988-07-11
NO158673C NO158673C (no) 1988-10-19

Family

ID=26349908

Family Applications (1)

Application Number Title Priority Date Filing Date
NO843377A NO158673C (no) 1983-08-24 1984-08-23 Analogifremgangsmaate ved fremstilling av terapeutisk aktive azurenderivater.

Country Status (13)

Country Link
US (1) US4595694A (no)
EP (1) EP0147915B1 (no)
KR (1) KR920000956B1 (no)
AR (1) AR240554A1 (no)
AU (1) AU571554B2 (no)
CA (1) CA1228862A (no)
DE (1) DE3463502D1 (no)
DK (1) DK169870B1 (no)
ES (1) ES535381A0 (no)
HU (1) HU195478B (no)
NO (1) NO158673C (no)
PT (1) PT79119B (no)
SU (1) SU1311618A3 (no)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5081152A (en) * 1989-07-05 1992-01-14 Kotobuki Seiyaku Co., Ltd. Azulene derivatives as thromboxane a2 and prostaglandin endoperoxide receptor antagonist
EP0887077A1 (de) * 1997-06-27 1998-12-30 Boehringer Mannheim Gmbh Verwendung von Azulenderivaten als Metalloproteaseinhibitoren
US6420435B1 (en) 1999-11-01 2002-07-16 Joe S. Wilkins, Jr. Method for treating gastrointestinal disorders
JP4202250B2 (ja) 2001-07-25 2008-12-24 バイオマリン ファーマシューティカル インコーポレイテッド 血液脳関門輸送を調節するための組成物および方法
US7041706B2 (en) * 2002-04-19 2006-05-09 Wilkins Jr Joe S Method for treating crohn's disease
EP2671507A3 (en) 2005-04-28 2014-02-19 Proteus Digital Health, Inc. Pharma-informatics system
MX2009002893A (es) 2006-09-18 2009-07-10 Raptor Pharmaceutical Inc Tratamiento de trastornos hepaticos mediante la administracion de conjugados de la proteina asociada al receptor (rap).
CA2752373C (en) 2009-02-20 2017-10-10 To-Bbb Holding B.V. Glutathione-based drug delivery system
IL255113B (en) 2009-05-06 2022-09-01 Laboratory Skin Care Inc Dermal delivery compositions comprising active agent-calcium phosphate particle complexes and methods of using the same
US20120077778A1 (en) 2010-09-29 2012-03-29 Andrea Bourdelais Ladder-Frame Polyether Conjugates

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1227896B (de) * 1965-12-02 1966-11-03 Degussa Verfahren zur Herstellung wasserloeslicher stabiler Salze von Azulensulfonsaeureamiden
US3816612A (en) * 1967-03-23 1974-06-11 Degussa Process for the production of basically reacting pharmaceuticals
US3974299A (en) * 1974-07-08 1976-08-10 Dynapol Ionic sweetener
US4283347A (en) * 1979-04-13 1981-08-11 Scm Corporation Para-menth-1-ene-7-sulfonic acid and salts thereof
US4224240A (en) * 1979-04-13 1980-09-23 Scm Corporation Preparation of para-menth-1-ene-7-sulfonate salts and corresponding acids

Also Published As

Publication number Publication date
PT79119B (en) 1986-07-17
DK169870B1 (da) 1995-03-20
US4595694A (en) 1986-06-17
HUT37393A (en) 1985-12-28
DE3463502D1 (en) 1987-06-11
CA1228862A (en) 1987-11-03
EP0147915A1 (en) 1985-07-10
NO158673B (no) 1988-07-11
SU1311618A3 (ru) 1987-05-15
PT79119A (en) 1984-09-01
KR920000956B1 (ko) 1992-01-31
DK377984D0 (da) 1984-08-03
ES8506607A1 (es) 1985-07-16
KR850001731A (ko) 1985-04-01
DK377984A (da) 1985-02-25
EP0147915B1 (en) 1987-05-06
ES535381A0 (es) 1985-07-16
HU195478B (en) 1988-05-30
AU3139684A (en) 1985-02-28
AU571554B2 (en) 1988-04-21
NO158673C (no) 1988-10-19
AR240554A1 (es) 1990-05-31

Similar Documents

Publication Publication Date Title
NO841568L (no) Fremgangsmaate for fremstilling av terapeutisk aktive fenetanolamin-derivater
NO843979L (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive 1-benzyl-aminoalkyl-pyrrolidinon-derivater
NO160521C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive 13alfa- alkylgonaner.
NO820479L (no) Fremgangsmaate for fremstilling av terapeutisk aktive carbostyrilderivater
NO851695L (no) Fremgangsmaate for fremstilling av terapeutisk aktive 2-(n-substituert-guanidino)-4-heteroaryl-tiazol-derivater
NO165192C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive glyserolderivater.
NO168355C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive benzimidazolderivater
NO814136L (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive 8-arylalkyl-3-fenyl-3-notropanol-derivater
NO167510C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive fenylkinolincarboxylsyrer
NO843084L (no) Fremgangsmaate for fremstilling av terapeutisk aktive adenosin-derivater
NO841542L (no) Fremgangsmaate for fremstilling av terapeutisk aktive indeno-pyridazinon-derivater
NO814055L (no) Fremgangsmaate ved fremstilling av terapeutisk aktive thienopyridinonderivater
NO161562C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive ergolinderivater.
NO843042L (no) Fremgangsmaate for fremstilling av terapeutisk aktive kumarin-derivater
NO854369L (no) Fremgangsmaate for fremstilling av terapeutisk aktive benzimidazol-derivater
NO844243L (no) Fremgangsmaate for fremstilling av terapeutisk virksomme forbindelser
NO168299C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive alkansulfonanilid-derivater
NO172489C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive imidazolderivater
NO158941C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive 4-piperidino-kinazolinderivater.
NO833527L (no) Fremgangsmaate for fremstilling av terapeutisk aktive fenyl-cyklobutylderivater
NO843377L (no) Fremgangsmaate ved fremstilling av terapeutisk aktive azurenderivater
NO169007C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive uridinderivater
NO161313C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive fluorallylaminderivater.
NO820112L (no) Fremgangsmaate for fremstilling av terapeutisk aktive pyridoindol-derivater
NO171501C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive 2-metoksymetylpenem-derivater